GLYCOPYRRONIUM

GLYCOPYRRONIUM was reported 1551 times

GLYCOPYRRONIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BUTTOCK CRUSHING 4 0.3077
1 BORDETELLA TEST POSITIVE 2 0.1250
2 ANIRIDIA 1 0.0833
3 FUNGAL TEST 1 0.0769
4 BLOOD CARBON MONOXIDE DECREASED 1 0.0667
5 LARYNGOSCOPY 1 0.0476
6 NON-FUNCTIONAL KIDNEY 1 0.0455
7 COMPENSATORY SWEATING 1 0.0357
8 HYPER IGE SYNDROME 4 0.0351
9 STAPHYLOCOCCAL SCALDED SKIN SYNDROME 7 0.0311
10 COLD AGGLUTININS 1 0.0303
11 CILIARY MUSCLE SPASM 1 0.0294
12 HOLMES-ADIE PUPIL 1 0.0263
13 TOTAL LUNG CAPACITY INCREASED 7 0.0257
14 MUCOPOLYSACCHARIDOSIS II 1 0.0213
15 BLOOD KETONE BODY DECREASED 1 0.0213
16 MYDRIASIS 273 0.0213
17 ANISOCORIA 7 0.0185
18 SALIVARY HYPOSECRETION 3 0.0185
19 HYPOHIDROSIS 9 0.0179
20 COMA SCALE 1 0.0164
21 ANHIDROSIS 6 0.0147
22 EXPOSURE VIA EYE CONTACT 6 0.0143
23 SCINTILLATING SCOTOMA 3 0.0136
24 ANTICHOLINERGIC EFFECT 1 0.0133
25 BARBITURATES POSITIVE 1 0.0125
26 BLADDER STENOSIS 1 0.0122
27 DRUG METABOLITE LEVEL HIGH 1 0.0119
28 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 6 0.0115
29 URINARY HESITATION 26 0.0109
30 APTYALISM 9 0.0105
31 VULVOVAGINAL CANDIDIASIS 14 0.0103
32 NEGATIVE PRESSURE PULMONARY OEDEMA 1 0.0102
33 ATRIOVENTRICULAR DISSOCIATION 2 0.0093
34 BODY MASS INDEX ABNORMAL 2 0.0082
35 ADMINISTRATION SITE DISCOLOURATION 1 0.0080
36 PROLONGED EXPIRATION 2 0.0076
37 CONJUNCTIVAL IRRITATION 1 0.0074
38 ADMINISTRATION SITE IRRITATION 1 0.0071
39 CYSTIC LUNG DISEASE 1 0.0070
40 APPLICATION SITE ODOUR 1 0.0069
41 PEAK EXPIRATORY FLOW RATE DECREASED 3 0.0068
42 PNEUMOCOCCAL INFECTION 4 0.0068
43 BONE LESION EXCISION 1 0.0066
44 CORNEA VERTICILLATA 2 0.0066
45 BLOOD CREATININE 1 0.0065
46 ABDOMINAL WALL WOUND 1 0.0065
47 FEEDING TUBE COMPLICATION 2 0.0064
48 ATTENTION-SEEKING BEHAVIOUR 1 0.0064
49 PUPILS UNEQUAL 7 0.0061
50 DYSDIADOCHOKINESIS 1 0.0058
51 BLOOD LACTIC ACID DECREASED 1 0.0058
52 PSEUDOMONAL SEPSIS 10 0.0057
53 GENITOURINARY SYMPTOM 1 0.0055
54 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 5 0.0054
55 EOSINOPHILIC BRONCHITIS 1 0.0050
56 PULMONARY CALCIFICATION 2 0.0048
57 KUSSMAUL RESPIRATION 1 0.0048
58 STOMA SITE HYPERGRANULATION 3 0.0048
59 NEUROMUSCULAR BLOCKADE 1 0.0045
60 NASAL DRYNESS 28 0.0045
61 ANTICHOLINERGIC SYNDROME 7 0.0044
62 BRONCHIAL WALL THICKENING 3 0.0042
63 DIABETIC VASCULAR DISORDER 1 0.0040
64 DRY THROAT 41 0.0040
65 INDIFFERENCE 3 0.0040
66 REDUCED FACIAL EXPRESSION 4 0.0039
67 ANTIPSYCHOTIC DRUG LEVEL DECREASED 2 0.0038
68 FAECAL VOMITING 2 0.0038
69 HEPATITIS B SURFACE ANTIGEN POSITIVE 1 0.0036
70 APPENDICITIS PERFORATED 9 0.0035
71 NON-SMALL CELL LUNG CANCER RECURRENT 1 0.0035
72 ANDROGENETIC ALOPECIA 1 0.0035
73 DEVICE LOOSENING 3 0.0035
74 PUPIL FIXED 6 0.0035
75 RESTRICTIVE PULMONARY DISEASE 4 0.0034
76 SALIVA ALTERED 3 0.0033
77 BRONCHOSPASM PARADOXICAL 1 0.0033
78 MYXOEDEMA COMA 1 0.0033
79 FOETAL CARDIAC DISORDER 1 0.0032
80 MENINGOCOCCAL INFECTION 1 0.0032
81 HYPERMETROPIA 3 0.0032
82 INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 2 0.0031
83 ELECTROCARDIOGRAM QRS COMPLEX ABNORMAL 1 0.0031
84 SPUTUM PURULENT 2 0.0030
85 CEREBRAL AMYLOID ANGIOPATHY 1 0.0030
86 GASTROENTERITIS NOROVIRUS 4 0.0030
87 LUNG ADENOCARCINOMA 9 0.0030
88 PRECANCEROUS CONDITION 2 0.0030
89 DRY MOUTH 241 0.0030
90 STOMA SITE REACTION 2 0.0029
91 OCULAR MYASTHENIA 1 0.0029
92 ACCOMMODATION DISORDER 2 0.0027
93 ILEUS PARALYTIC 12 0.0027
94 SERRATIA INFECTION 2 0.0027
95 STOMA SITE INFLAMMATION 2 0.0027
96 URINARY RETENTION 89 0.0027
97 BRONCHOPLEURAL FISTULA 1 0.0027
98 HEAT STROKE 4 0.0026
99 POLYCYSTIC OVARIES 4 0.0026
100 LUNG DIFFUSION TEST DECREASED 1 0.0025
101 EXCESSIVE GRANULATION TISSUE 2 0.0025
102 CLUBBING 1 0.0025
103 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 2 0.0024
104 BRADYCARDIA FOETAL 2 0.0024
105 ABDOMINAL CAVITY DRAINAGE 1 0.0024
106 JOINT SURGERY 1 0.0023
107 DYSCHEZIA 7 0.0023
108 FIBROMA 2 0.0022
109 HERNIA PAIN 1 0.0022
110 ANASTOMOTIC ULCER 1 0.0022
111 MONONEUROPATHY MULTIPLEX 1 0.0022
112 PUPILLARY REFLEX IMPAIRED 4 0.0022
113 EHLERS-DANLOS SYNDROME 1 0.0022
114 BRONCHIAL OBSTRUCTION 3 0.0021
115 CRANIAL NERVE PARALYSIS 1 0.0021
116 LACRIMATION DECREASED 1 0.0021
117 MOTOR NEURONE DISEASE 1 0.0021
118 SKIN ODOUR ABNORMAL 8 0.0020
119 HYPERTHERMIA MALIGNANT 3 0.0020
120 SMALL CELL LUNG CANCER 3 0.0020
121 LOWER RESPIRATORY TRACT INFECTION VIRAL 1 0.0020
122 DRUG LEVEL ABNORMAL 1 0.0019
123 ABNORMAL SENSATION IN EYE 8 0.0019
124 INTERTRIGO 1 0.0018
125 NASAL POLYPS 9 0.0018
126 STOMA SITE DISCHARGE 5 0.0018
127 NAIL DYSTROPHY 1 0.0018
128 BACTERIURIA 1 0.0018
129 MOANING 2 0.0018
130 LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR 1 0.0017
131 ADENOMYOSIS 1 0.0017
132 BRONCHIECTASIS 11 0.0016
133 PHARYNGEAL HAEMORRHAGE 2 0.0016
134 ELBOW OPERATION 1 0.0016
135 DRUG LEVEL CHANGED 1 0.0016
136 SUBCUTANEOUS HAEMATOMA 2 0.0016
137 CHANGE IN SEIZURE PRESENTATION 1 0.0015
138 CONVERSION DISORDER 3 0.0015
139 HYPOVENTILATION 5 0.0015
140 FORCED VITAL CAPACITY DECREASED 1 0.0015
141 FOAMING AT MOUTH 3 0.0015
142 MICTURITION DISORDER 5 0.0014
143 GLASSY EYES 1 0.0014
144 FORCED EXPIRATORY VOLUME DECREASED 4 0.0014
145 CHYLOTHORAX 1 0.0014
146 ALANINE AMINOTRANSFERASE DECREASED 1 0.0014
147 VISION BLURRED 188 0.0014
148 FREEZING PHENOMENON 5 0.0013
149 DECUBITUS ULCER 11 0.0013
150 RHINITIS ALLERGIC 6 0.0013
151 HYDRONEPHROSIS 10 0.0013
152 ASPIRATION PLEURAL CAVITY 1 0.0013
153 PULMONARY FUNCTION TEST ABNORMAL 2 0.0013
154 MYOPERICARDITIS 1 0.0013
155 DRUG TOLERANCE INCREASED 1 0.0013
156 DYSURIA 47 0.0013
157 PLACENTA PRAEVIA 1 0.0013
158 OPHTHALMOPLEGIA 2 0.0013
159 EYELID FUNCTION DISORDER 1 0.0013
160 INHIBITORY DRUG INTERACTION 2 0.0013
161 SARCOIDOSIS 6 0.0013
162 ON AND OFF PHENOMENON 7 0.0013
163 URINE FLOW DECREASED 3 0.0013
164 HAPTOGLOBIN DECREASED 1 0.0012
165 IIIRD NERVE PARALYSIS 1 0.0012
166 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
167 MOUTH SWELLING 7 0.0012
168 DYSCHROMATOPSIA 1 0.0012
169 OVARIAN CANCER METASTATIC 1 0.0012
170 INCREASED BRONCHIAL SECRETION 3 0.0012
171 ATONIC SEIZURES 1 0.0012
172 LUNG HYPERINFLATION 1 0.0012
173 THYROIDECTOMY 2 0.0012
174 FOOD REFUSAL 1 0.0011
175 JAUNDICE CHOLESTATIC 4 0.0011
176 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 1 0.0011
177 ANAESTHETIC COMPLICATION NEUROLOGICAL 1 0.0011
178 COLOUR BLINDNESS 1 0.0011
179 HYPOMANIA 4 0.0011
180 OTOTOXICITY 2 0.0011
181 BIOPSY 1 0.0011
182 OBSTRUCTIVE AIRWAYS DISORDER 12 0.0011
183 INTENTIONAL PRODUCT MISUSE 94 0.0011
184 STOMA SITE ERYTHEMA 2 0.0011
185 ORAL CANDIDIASIS 14 0.0011
186 DELAYED RECOVERY FROM ANAESTHESIA 1 0.0011
187 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
188 ANIMAL SCRATCH 1 0.0010
189 CARDIAC ANEURYSM 1 0.0010
190 DEVICE RELATED SEPSIS 2 0.0010
191 FALSE POSITIVE INVESTIGATION RESULT 1 0.0010
192 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 2 0.0010
193 BODY TEMPERATURE FLUCTUATION 2 0.0010
194 PHOTOPHOBIA 18 0.0010
195 COGWHEEL RIGIDITY 1 0.0010
196 PHARYNGEAL ERYTHEMA 2 0.0009
197 ENTERITIS 6 0.0009
198 HYPOMAGNESAEMIA 13 0.0009
199 HIP SURGERY 5 0.0009
200 BLADDER DILATATION 1 0.0009
201 CLAUSTROPHOBIA 1 0.0009
202 CONJUNCTIVITIS 17 0.0009
203 TONGUE DISCOLOURATION 4 0.0009
204 DRY EYE 45 0.0009
205 SALIVARY HYPERSECRETION 9 0.0009
206 TEMPERATURE REGULATION DISORDER 2 0.0009
207 POTENTIATING DRUG INTERACTION 3 0.0009
208 MYOCARDIAL INJURY 1 0.0009
209 ADMINISTRATION SITE PAIN 1 0.0009
210 PERIPHERAL EMBOLISM 1 0.0009
211 MUCOSAL HAEMORRHAGE 1 0.0009
212 OPTIC NERVE INJURY 1 0.0009
213 BRONCHIOLITIS 3 0.0009
214 BRONCHIAL HYPERREACTIVITY 1 0.0008
215 APHAGIA 4 0.0008
216 APPLICATION SITE HYPERSENSITIVITY 1 0.0008
217 THROMBOCYTOSIS 3 0.0008
218 BLADDER DISCOMFORT 1 0.0008
219 CHRONIC SINUSITIS 3 0.0008
220 NASAL PRURITUS 1 0.0008
221 DYSLIPIDAEMIA 4 0.0008
222 BRONCHIAL SECRETION RETENTION 1 0.0008
223 LIP HAEMORRHAGE 1 0.0008
224 SEROTONIN SYNDROME 15 0.0008
225 VENTRICULAR DYSFUNCTION 2 0.0008
226 ADJUSTMENT DISORDER 1 0.0008
227 LUNG OPACITY 2 0.0008
228 LIP EXFOLIATION 1 0.0008
229 ANION GAP INCREASED 1 0.0007
230 BREAST SWELLING 2 0.0007
231 LARYNGOSPASM 2 0.0007
232 ENURESIS 3 0.0007
233 NEUROMYELITIS OPTICA SPECTRUM DISORDER 1 0.0007
234 RESPIRATORY DEPRESSION 9 0.0007
235 ISCHAEMIC HEPATITIS 1 0.0007
236 ECCHYMOSIS 5 0.0007
237 CHOKING SENSATION 4 0.0007
238 GENERALISED TONIC-CLONIC SEIZURE 12 0.0007
239 APPLICATION SITE INFLAMMATION 1 0.0007
240 LUNG CONSOLIDATION 2 0.0007
241 ECHOCARDIOGRAM ABNORMAL 1 0.0007
242 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0007
243 CULTURE URINE POSITIVE 1 0.0007
244 CONNECTIVE TISSUE DISORDER 1 0.0007
245 RESPIRATORY SYMPTOM 2 0.0007
246 CHORIORETINOPATHY 1 0.0007
247 LUNG NEOPLASM 3 0.0007
248 DERMATITIS CONTACT 8 0.0007
249 GENITAL RASH 1 0.0007
250 BLOOD MAGNESIUM DECREASED 6 0.0007
251 FEEDING DISORDER 14 0.0007
252 OBSTRUCTIVE SLEEP APNOEA SYNDROME 1 0.0007
253 STRIDOR 2 0.0007
254 AXILLARY PAIN 1 0.0007
255 GASTRITIS HAEMORRHAGIC 1 0.0007
256 MYOCLONIC EPILEPSY 1 0.0007
257 MOUTH INJURY 1 0.0007
258 MANTLE CELL LYMPHOMA 1 0.0007
259 PALLIATIVE CARE 1 0.0007
260 SPUTUM DISCOLOURED 6 0.0006
261 DISINHIBITION 1 0.0006
262 REBOUND EFFECT 7 0.0006
263 VULVOVAGINAL DRYNESS 2 0.0006
264 THIRST 11 0.0006
265 PITUITARY TUMOUR BENIGN 1 0.0006
266 NEAR DEATH EXPERIENCE 2 0.0006
267 MITRAL VALVE PROLAPSE 1 0.0006
268 ERYSIPELAS 3 0.0006
269 APPLICATION SITE DRYNESS 2 0.0006
270 MUSCLE RIGIDITY 7 0.0006
271 CERVICAL SPINAL STENOSIS 1 0.0006
272 CARDIAC MURMUR 5 0.0006
273 TACHYPHRENIA 2 0.0006
274 PARTIAL SEIZURES 3 0.0006
275 BREAST CYST 1 0.0006
276 ILEUS 7 0.0006
277 PRODUCT CONTAMINATION 2 0.0006
278 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
279 APPLICATION SITE DISCOMFORT 1 0.0006
280 OROPHARYNGEAL PAIN 51 0.0006
281 ASPIRATION 6 0.0005
282 BODY TEMPERATURE ABNORMAL 1 0.0005
283 IMPATIENCE 1 0.0005
284 HYPERTHERMIA 4 0.0005
285 PANCREATIC CYST 1 0.0005
286 MOTION SICKNESS 1 0.0005
287 HYPERVENTILATION 3 0.0005
288 APNOEA 4 0.0005
289 NASAL SEPTUM DEVIATION 1 0.0005
290 PHARYNGEAL SWELLING 5 0.0005
291 APPLICATION SITE PAIN 11 0.0005
292 MUCOSAL DRYNESS 1 0.0005
293 TOXIC SKIN ERUPTION 5 0.0005
294 RHINITIS 4 0.0005
295 TENSION 3 0.0005
296 IMMUNE-MEDIATED HEPATITIS 1 0.0005
297 LOWER RESPIRATORY TRACT INFECTION 22 0.0005
298 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
299 DEVICE MATERIAL ISSUE 1 0.0005
300 DEVICE CONNECTION ISSUE 1 0.0005
301 INCONTINENCE 5 0.0005
302 FULL BLOOD COUNT ABNORMAL 5 0.0005
303 HYPERKINESIA 1 0.0005
304 BRADYCARDIA 25 0.0005
305 METABOLIC ACIDOSIS 15 0.0005
306 CHAPPED LIPS 2 0.0005
307 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 1 0.0005
308 NOSOCOMIAL INFECTION 1 0.0005
309 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
310 INFECTIOUS MONONUCLEOSIS 1 0.0004
311 GASTROINTESTINAL HYPOMOTILITY 1 0.0004
312 DYSPHAGIA 42 0.0004
313 DISTRIBUTIVE SHOCK 1 0.0004
314 VASCULAR DEVICE INFECTION 2 0.0004
315 LIP DRY 4 0.0004
316 FLAT AFFECT 1 0.0004
317 NEUROPATHY PERIPHERAL 41 0.0004
318 HAEMOPTYSIS 12 0.0004
319 APHONIA 6 0.0004
320 PERFORMANCE STATUS DECREASED 2 0.0004
321 BLOOD TEST ABNORMAL 6 0.0004
322 APPLICATION SITE REACTION 3 0.0004
323 VENTRICULAR TACHYCARDIA 7 0.0004
324 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 22 0.0004
325 MYOPIA 1 0.0004
326 SLEEP APNOEA SYNDROME 8 0.0004
327 OXYGEN CONSUMPTION INCREASED 1 0.0004
328 DRUG PRESCRIBING ERROR 8 0.0004
329 CIRCULATORY COLLAPSE 7 0.0004
330 BREATH SOUNDS ABNORMAL 2 0.0004
331 WHEEZING 24 0.0004
332 DEVICE INFUSION ISSUE 1 0.0004
333 APPLICATION SITE IRRITATION 5 0.0004
334 ANEURYSM 2 0.0004
335 CATHETER SITE HAEMORRHAGE 1 0.0004
336 HYPERHIDROSIS 51 0.0004
337 ANGLE CLOSURE GLAUCOMA 1 0.0004
338 BRONCHOPULMONARY ASPERGILLOSIS 3 0.0004
339 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
340 ACCIDENTAL EXPOSURE TO PRODUCT 39 0.0004
341 SENSORY DISTURBANCE 6 0.0004
342 PRODUCT RESIDUE PRESENT 2 0.0004
343 CLUMSINESS 1 0.0004
344 ABNORMAL FAECES 3 0.0004
345 ORAL FUNGAL INFECTION 1 0.0004
346 CHOKING 7 0.0004
347 ACUTE PULMONARY OEDEMA 2 0.0004
348 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 6 0.0004
349 OXYGEN SATURATION ABNORMAL 1 0.0004
350 SUBDURAL HAEMATOMA 5 0.0003
351 MYOCARDITIS 4 0.0003
352 HYPERTONIC BLADDER 1 0.0003
353 DELIRIUM 12 0.0003
354 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
355 HYPOTHYROIDISM 11 0.0003
356 RALES 2 0.0003
357 EOSINOPHILIA 6 0.0003
358 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
359 NECK INJURY 1 0.0003
360 LYMPHOPROLIFERATIVE DISORDER 1 0.0003
361 BRADYKINESIA 2 0.0003
362 CREPITATIONS 1 0.0003
363 PULMONARY MASS 5 0.0003
364 ODYNOPHAGIA 2 0.0003
365 BLOOD BILIRUBIN INCREASED 9 0.0003
366 MYELOFIBROSIS 1 0.0003
367 CONSTIPATION 72 0.0003
368 EMERGENCY CARE 1 0.0003
369 SCHIZOPHRENIA 4 0.0003
370 MEDICAL DEVICE DISCOMFORT 1 0.0003
371 ISCHAEMIC CARDIOMYOPATHY 1 0.0003
372 RECTAL HAEMORRHAGE 14 0.0003
373 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 2 0.0003
374 DRY SKIN 43 0.0003
375 MIDDLE INSOMNIA 6 0.0003
376 PRE-EXISTING CONDITION IMPROVED 2 0.0003
377 BLOOD BLISTER 1 0.0003
378 SECRETION DISCHARGE 4 0.0003
379 BLOOD CREATININE DECREASED 1 0.0003
380 FOREIGN BODY IN THROAT 1 0.0003
381 HYPOCALCAEMIA 6 0.0003
382 DRUG INTERACTION 50 0.0003
383 BLADDER PAIN 1 0.0003
384 PULMONARY FIBROSIS 6 0.0003
385 HYPOXIA 11 0.0003
386 HIATUS HERNIA 4 0.0003
387 BLOOD CREATININE INCREASED 20 0.0003
388 INJECTION SITE INFECTION 1 0.0003
389 WALKING AID USER 2 0.0003
390 CARDIAC FAILURE ACUTE 2 0.0003
391 EMPHYSEMA 3 0.0003
392 UPPER GASTROINTESTINAL HAEMORRHAGE 5 0.0003
393 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 2 0.0003
394 INITIAL INSOMNIA 3 0.0003
395 DYSPNOEA EXERTIONAL 11 0.0003
396 ASTHMA 33 0.0003
397 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 14 0.0003
398 HYPOPNOEA 1 0.0003
399 RHABDOMYOLYSIS 12 0.0003
400 POLLAKIURIA 12 0.0003
401 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
402 AORTIC STENOSIS 1 0.0003
403 PRODUCT ODOUR ABNORMAL 3 0.0003
404 WOUND 8 0.0003
405 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
406 COLD SWEAT 5 0.0003
407 DEPRESSIVE SYMPTOM 1 0.0003
408 NEUTROPENIC SEPSIS 2 0.0003
409 LETHARGY 16 0.0003
410 APPARENT DEATH 1 0.0003
411 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
412 FOOD INTOLERANCE 1 0.0003
413 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 5 0.0003
414 GASTROINTESTINAL PAIN 3 0.0003
415 PRODUCTIVE COUGH 13 0.0003
416 RASH MACULO-PAPULAR 6 0.0003
417 IMPULSIVE BEHAVIOUR 1 0.0003
418 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 54 0.0003
419 STATUS EPILEPTICUS 3 0.0003
420 BREAST TENDERNESS 2 0.0003
421 STOMATITIS 16 0.0003
422 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
423 PANIC DISORDER 1 0.0003
424 DYSTONIA 5 0.0003
425 FAECES HARD 1 0.0003
426 SKIN FISSURES 5 0.0003
427 MULTIPLE ALLERGIES 2 0.0003
428 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
429 RESPIRATORY DISTRESS 7 0.0003
430 PNEUMOTHORAX 4 0.0003
431 MYOCLONUS 3 0.0003
432 EXPOSURE VIA BREAST MILK 1 0.0003
433 ABSCESS 4 0.0003
434 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
435 MIOSIS 2 0.0002
436 HYPONATRAEMIA 14 0.0002
437 FRUSTRATION TOLERANCE DECREASED 2 0.0002
438 ADRENAL INSUFFICIENCY 3 0.0002
439 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
440 APPLICATION SITE DISCOLOURATION 1 0.0002
441 DYSKINESIA 10 0.0002
442 SPINAL OPERATION 3 0.0002
443 ESCHERICHIA INFECTION 2 0.0002
444 ANAPHYLACTOID REACTION 1 0.0002
445 PHOTOSENSITIVITY REACTION 4 0.0002
446 LIVER FUNCTION TEST ABNORMAL 7 0.0002
447 HALLUCINATIONS, MIXED 1 0.0002
448 HAEMATEMESIS 6 0.0002
449 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
450 CARDIAC FAILURE CHRONIC 1 0.0002
451 BLOOD POTASSIUM DECREASED 7 0.0002
452 ANURIA 2 0.0002
453 FEELING HOT 14 0.0002
454 BLOOD CALCIUM INCREASED 2 0.0002
455 PULMONARY CONGESTION 3 0.0002
456 HAEMORRHAGIC ANAEMIA 1 0.0002
457 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 2 0.0002
458 RESPIRATORY RATE INCREASED 2 0.0002
459 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 16 0.0002
460 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
461 OFF LABEL USE 195 0.0002
462 ANAL INCONTINENCE 2 0.0002
463 DYSPHONIA 13 0.0002
464 OROPHARYNGEAL DISCOMFORT 2 0.0002
465 RESTLESS LEGS SYNDROME 4 0.0002
466 PATHOGEN RESISTANCE 2 0.0002
467 LUNG NEOPLASM MALIGNANT 9 0.0002
468 LUMBAR VERTEBRAL FRACTURE 1 0.0002
469 UROSEPSIS 2 0.0002
470 PERICARDIAL EFFUSION 5 0.0002
471 PLEURAL EFFUSION 13 0.0002
472 ENDOMETRIOSIS 1 0.0002
473 IMPAIRED QUALITY OF LIFE 3 0.0002
474 LIMB OPERATION 1 0.0002
475 SINUS BRADYCARDIA 2 0.0002
476 APATHY 3 0.0002
477 PRESYNCOPE 5 0.0002
478 DYSSTASIA 6 0.0002
479 OEDEMA PERIPHERAL 25 0.0002
480 ASCITES 6 0.0002
481 TACHYCARDIA 18 0.0002
482 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
483 DISABILITY 4 0.0002
484 HYPERNATRAEMIA 1 0.0002
485 AGEUSIA 5 0.0002
486 FLUID INTAKE REDUCED 1 0.0002
487 ANAPHYLACTIC REACTION 11 0.0002
488 PRODUCT ADMINISTRATION ERROR 4 0.0002
489 HYPOTHERMIA 2 0.0002
490 MOTOR DYSFUNCTION 2 0.0002
491 BODY TEMPERATURE INCREASED 4 0.0002
492 INCREASED UPPER AIRWAY SECRETION 1 0.0002
493 VISUAL IMPAIRMENT 24 0.0002
494 DELUSION 3 0.0002
495 SWOLLEN TONGUE 6 0.0002
496 RESPIRATORY FAILURE 14 0.0002
497 MALABSORPTION 1 0.0002
498 APPLICATION SITE ERYTHEMA 5 0.0002
499 BLOOD LACTIC ACID INCREASED 1 0.0002
500 JOINT INJURY 4 0.0002
501 FOOD POISONING 1 0.0002
502 GASTROOESOPHAGEAL REFLUX DISEASE 15 0.0002
503 DYSARTHRIA 7 0.0002
504 INJECTION SITE DISCHARGE 1 0.0002
505 BRUXISM 1 0.0002
506 CHEILITIS 1 0.0002
507 PHARYNGITIS STREPTOCOCCAL 2 0.0002
508 PULMONARY THROMBOSIS 2 0.0002
509 NONSPECIFIC REACTION 1 0.0002
510 PNEUMONIA 59 0.0002
511 ASTHENOPIA 1 0.0002
512 LIP SWELLING 6 0.0002
513 NERVE INJURY 2 0.0002
514 HEPATOTOXICITY 4 0.0002
515 HEART RATE ABNORMAL 1 0.0002
516 OCULAR DISCOMFORT 2 0.0002
517 MULTIPLE USE OF SINGLE-USE PRODUCT 1 0.0002
518 CANDIDA INFECTION 3 0.0002
519 EXPOSURE DURING PREGNANCY 11 0.0002
520 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
521 CHOLECYSTITIS ACUTE 1 0.0002
522 GENERALISED ERYTHEMA 1 0.0002
523 CARDIAC VALVE DISEASE 1 0.0002
524 HYPERTONIA 1 0.0002
525 CARDIAC FAILURE 14 0.0002
526 EPISTAXIS 13 0.0002
527 EXERCISE TOLERANCE DECREASED 1 0.0002
528 BLOOD URIC ACID INCREASED 1 0.0002
529 GENERAL PHYSICAL HEALTH DETERIORATION 20 0.0002
530 MUSCULOSKELETAL STIFFNESS 15 0.0002
531 SPINAL PAIN 2 0.0002
532 URINARY TRACT INFECTION 29 0.0002
533 OCULAR HYPERAEMIA 8 0.0002
534 RESPIRATORY DISORDER 5 0.0002
535 INGUINAL HERNIA 1 0.0002
536 RESTLESSNESS 6 0.0002
537 SMALL INTESTINAL OBSTRUCTION 2 0.0002
538 LARYNGEAL OEDEMA 1 0.0002
539 PIGMENTATION DISORDER 1 0.0002
540 GENERALISED OEDEMA 2 0.0002
541 LEUKOPENIA 8 0.0002
542 FOREIGN BODY SENSATION IN EYES 1 0.0002
543 HYPOPHAGIA 4 0.0002
544 THERAPEUTIC PRODUCT EFFECT DECREASED 7 0.0002
545 DIPLOPIA 4 0.0002
546 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
547 NODULE 2 0.0002
548 SKIN IRRITATION 7 0.0002
549 TOOTH INFECTION 2 0.0002
550 HYPOKALAEMIA 7 0.0002
551 ABNORMAL BEHAVIOUR 6 0.0002
552 DISORIENTATION 6 0.0002
553 APPETITE DISORDER 1 0.0002
554 VISUAL ACUITY REDUCED 5 0.0002
555 DEHYDRATION 20 0.0001
556 SYNCOPE 15 0.0001
557 EYE HAEMORRHAGE 2 0.0001
558 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
559 PAIN OF SKIN 4 0.0001
560 THROAT TIGHTNESS 4 0.0001
561 TASTE DISORDER 3 0.0001
562 TACHYPNOEA 2 0.0001
563 MIGRAINE 14 0.0001
564 AKATHISIA 2 0.0001
565 SKIN LESION 4 0.0001
566 PERIPHERAL COLDNESS 2 0.0001
567 APPLICATION SITE RASH 2 0.0001
568 HAIR GROWTH ABNORMAL 1 0.0001
569 LARGE INTESTINE PERFORATION 1 0.0001
570 ORAL DISCOMFORT 2 0.0001
571 FORMICATION 1 0.0001
572 DEMENTIA 4 0.0001
573 OXYGEN SATURATION DECREASED 8 0.0001
574 DIVERTICULUM 1 0.0001
575 POOR QUALITY SLEEP 3 0.0001
576 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
577 MYELODYSPLASTIC SYNDROME 2 0.0001
578 DEVICE DISLOCATION 6 0.0001
579 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
580 FAECES SOFT 1 0.0001
581 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
582 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
583 CHEST DISCOMFORT 14 0.0001
584 BLINDNESS TRANSIENT 1 0.0001
585 HEADACHE 85 0.0001
586 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
587 HYPOPHOSPHATAEMIA 1 0.0001
588 CEREBRAL DISORDER 1 0.0001
589 PULMONARY OEDEMA 6 0.0001
590 SNEEZING 3 0.0001
591 CORONARY ARTERY DISEASE 4 0.0001
592 BOWEL MOVEMENT IRREGULARITY 1 0.0001
593 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
594 LYMPHOMA 2 0.0001
595 HYPOALBUMINAEMIA 1 0.0001
596 COGNITIVE DISORDER 6 0.0001
597 PELVIC FRACTURE 1 0.0001
598 INSOMNIA 34 0.0001
599 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 7 0.0001
600 CYANOSIS 2 0.0001
601 NASAL DISCOMFORT 1 0.0001
602 GINGIVAL PAIN 1 0.0001
603 SCIATICA 2 0.0001
604 MYASTHENIA GRAVIS 1 0.0001
605 CONFUSIONAL STATE 20 0.0001
606 LACTIC ACIDOSIS 4 0.0001
607 PRODUCT DOSE OMISSION 8 0.0001
608 ASPHYXIA 1 0.0001
609 CHOLELITHIASIS 4 0.0001
610 DYSPNOEA 69 0.0001
611 HICCUPS 1 0.0001
612 EYE IRRITATION 7 0.0001
613 EXPIRED PRODUCT ADMINISTERED 4 0.0001
614 PNEUMONIA ASPIRATION 3 0.0001
615 EOSINOPHIL COUNT INCREASED 1 0.0001
616 PALPITATIONS 14 0.0001
617 NASAL CONGESTION 7 0.0001
618 ABDOMINAL PAIN LOWER 3 0.0001
619 PERIPHERAL SWELLING 18 0.0001
620 MYOPATHY 1 0.0001
621 HYSTERECTOMY 1 0.0001
622 RESPIRATORY TRACT INFECTION 3 0.0001
623 ECZEMA 6 0.0001
624 COUGH 32 0.0001
625 GASTRITIS 3 0.0001
626 GRIP STRENGTH DECREASED 1 0.0001
627 IMMUNOSUPPRESSION 1 0.0001
628 LUNG INFILTRATION 1 0.0001
629 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
630 SEIZURE 13 0.0001
631 ISCHAEMIC STROKE 2 0.0001
632 FACIAL PAIN 1 0.0001
633 HAEMOLYTIC ANAEMIA 1 0.0001
634 MOBILITY DECREASED 8 0.0001
635 OEDEMA 6 0.0001
636 PALLOR 3 0.0001
637 GASTROINTESTINAL CARCINOMA 1 0.0001
638 WRONG TECHNIQUE IN DRUG USAGE PROCESS 4 0.0001
639 OPTIC NEURITIS 1 0.0001
640 SOMNOLENCE 22 0.0001
641 CARDIAC ARREST 9 0.0001
642 SKIN DISCOLOURATION 5 0.0001
643 NERVE COMPRESSION 1 0.0001
644 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
645 CHEST PAIN 20 0.0001
646 FEELING COLD 3 0.0001
647 AGRANULOCYTOSIS 2 0.0001
648 PANCYTOPENIA 6 0.0001
649 ERYTHEMA MULTIFORME 1 0.0001
650 APPENDICITIS 1 0.0001
651 FLANK PAIN 1 0.0001
652 INFUSION RELATED REACTION 7 0.0001
653 ABDOMINAL DISTENSION 11 0.0001
654 BLOOD URINE PRESENT 2 0.0001
655 INTENTIONAL DOSE OMISSION 3 0.0001
656 ANGINA PECTORIS 3 0.0001
657 HYPOTENSION 21 0.0001
658 INCREASED APPETITE 2 0.0001
659 ACUTE KIDNEY INJURY 16 0.0001
660 POST PROCEDURAL COMPLICATION 2 0.0001
661 PYREXIA 36 0.0001
662 GLAUCOMA 2 0.0001
663 HYPERCHOLESTEROLAEMIA 1 0.0001
664 ATELECTASIS 1 0.0001
665 ABDOMINAL PAIN 24 0.0001
666 BODY TEMPERATURE DECREASED 1 0.0001
667 PSYCHOTIC DISORDER 3 0.0001
668 URINARY INCONTINENCE 3 0.0001
669 EMBEDDED DEVICE 1 0.0001
670 HEART RATE INCREASED 10 0.0001
671 PRODUCT USE IN UNAPPROVED INDICATION 25 0.0001
672 PRODUCT PHYSICAL ISSUE 2 0.0001
673 EYELID PTOSIS 1 0.0001
674 DRUG LEVEL DECREASED 1 0.0001
675 EPILEPSY 3 0.0001
676 SKIN BURNING SENSATION 7 0.0001
677 ADVERSE EVENT 9 0.0001
678 MALIGNANT NEOPLASM PROGRESSION 10 0.0001
679 EAR DISCOMFORT 1 0.0001
680 THERAPY CESSATION 5 0.0001
681 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
682 HYPERBILIRUBINAEMIA 1 0.0001
683 NERVOUS SYSTEM DISORDER 3 0.0001
684 FOLLICULITIS 1 0.0001
685 AGITATION 7 0.0001
686 HALLUCINATION, VISUAL 2 0.0001
687 DECREASED APPETITE 22 0.0001
688 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
689 BREAST CANCER METASTATIC 1 0.0001
690 DISTURBANCE IN ATTENTION 5 0.0001
691 UNEVALUABLE EVENT 7 0.0001
692 ATRIAL FIBRILLATION 9 0.0001
693 SEPTIC SHOCK 4 0.0001
694 EYE DISORDER 3 0.0001
695 DEPENDENCE 5 0.0001
696 MELAENA 2 0.0001
697 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
698 TRANSAMINASES INCREASED 2 0.0001
699 EYE PRURITUS 3 0.0001
700 TYPE 2 DIABETES MELLITUS 3 0.0001
701 INTESTINAL PERFORATION 1 0.0001
702 FISTULA 1 0.0001
703 APPLICATION SITE PRURITUS 2 0.0001
704 MYOCARDIAL ISCHAEMIA 1 0.0001
705 MICTURITION URGENCY 1 0.0001
706 ELECTROLYTE IMBALANCE 1 0.0001
707 HYPERTENSION 18 0.0001
708 ATAXIA 1 0.0001
709 BACTERAEMIA 1 0.0001
710 DISEASE RECURRENCE 4 0.0001
711 COMA 4 0.0001
712 HYPERLIPIDAEMIA 1 0.0001
713 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
714 RENAL IMPAIRMENT 7 0.0001
715 PRURITUS 32 0.0001
716 CONTUSION 8 0.0001
717 HYPOGLYCAEMIA 4 0.0001
718 PANIC ATTACK 3 0.0001
719 NEURALGIA 2 0.0001
720 CONDITION AGGRAVATED 25 0.0001
721 CYTOPENIA 1 0.0001
722 LUNG DISORDER 4 0.0001
723 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
724 HYPERSENSITIVITY 15 0.0001
725 EYE SWELLING 3 0.0001
726 PHARYNGITIS 1 0.0001
727 EXTRAPYRAMIDAL DISORDER 2 0.0001
728 MEMORY IMPAIRMENT 11 0.0001
729 INTENTIONAL PRODUCT USE ISSUE 7 0.0001
730 ASTHENIA 30 0.0001
731 DERMATITIS ALLERGIC 1 0.0001
732 DEPRESSION 18 0.0001
733 MUSCLE ATROPHY 1 0.0001
734 WEIGHT DECREASED 22 0.0001
735 INTRAOCULAR PRESSURE INCREASED 1 0.0001
736 GASTROINTESTINAL DISORDER 7 0.0001
737 ILLNESS 8 0.0001
738 UNRESPONSIVE TO STIMULI 2 0.0001
739 SKIN ULCER 2 0.0001
740 PARAESTHESIA 12 0.0001
741 IMMUNE SYSTEM DISORDER 1 0.0001
742 ANKYLOSING SPONDYLITIS 1 0.0001
743 BLOOD PRESSURE DECREASED 5 0.0001
744 HAIR TEXTURE ABNORMAL 1 0.0001
745 MALIGNANT MELANOMA 1 0.0001
746 JOINT RANGE OF MOTION DECREASED 1 0.0001
747 PRODUCT USE ISSUE 14 0.0001
748 FEAR 2 0.0001
749 EXTRA DOSE ADMINISTERED 3 0.0001
750 FREQUENT BOWEL MOVEMENTS 2 0.0001
751 LIMB INJURY 2 0.0001
752 BLINDNESS 3 0.0001
753 DRUG INEFFECTIVE 97 0.0001
754 IMPAIRED GASTRIC EMPTYING 1 0.0001
755 ERYTHEMA 15 0.0001
756 CORONARY ARTERY OCCLUSION 1 0.0001
757 RESPIRATORY ARREST 2 0.0001
758 TREMOR 12 0.0001
759 MEDICATION ERROR 4 0.0001
760 HUNGER 1 0.0001
761 SEPSIS 8 0.0001
762 MASS 1 0.0001
763 DIARRHOEA 46 0.0001
764 DEVICE OCCLUSION 1 0.0001
765 EYE PAIN 4 0.0001
766 LYMPHOPENIA 1 0.0001
767 HEPATOCELLULAR INJURY 1 0.0001
768 NASOPHARYNGITIS 13 0.0001
769 DIZZINESS 35 0.0001
770 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
771 BRONCHOSPASM 1 0.0001
772 PARALYSIS 1 0.0001
773 CARDIOGENIC SHOCK 1 0.0001
774 BALANCE DISORDER 6 0.0001
775 FALL 23 0.0001
776 INFECTION 10 0.0001
777 INJECTION SITE HAEMATOMA 1 0.0001
778 RASH 30 0.0001
779 GASTROENTERITIS 1 0.0001
780 SURGERY 4 0.0001
781 NAUSEA 54 0.0001
782 HAEMOGLOBIN DECREASED 7 0.0001
783 CARDIOMYOPATHY 1 0.0001
784 HAEMORRHAGE INTRACRANIAL 1 0.0001
785 THROAT IRRITATION 3 0.0001
786 THERAPY NON-RESPONDER 3 0.0001
787 HALLUCINATION 5 0.0001
788 HEPATIC FAILURE 2 0.0001
789 NEUTROPENIA 9 0.0001
790 ECONOMIC PROBLEM 1 0.0001
791 BLOOD COUNT ABNORMAL 1 0.0001
792 CHRONIC KIDNEY DISEASE 5 0.0001
793 VERTIGO 4 0.0001
794 BLOOD PRESSURE INCREASED 10 0.0001
795 NEPHROLITHIASIS 3 0.0001
796 TINNITUS 3 0.0001
797 OVERDOSE 14 0.0001
798 MUSCULOSKELETAL CHEST PAIN 1 0.0001
799 ANKLE FRACTURE 1 0.0001
800 LUNG INFECTION 1 0.0001
801 EJECTION FRACTION DECREASED 1 0.0001
802 ACUTE MYELOID LEUKAEMIA 1 0.0001
803 BRAIN FOG 1 0.0001
804 DRUG-INDUCED LIVER INJURY 2 0.0001
805 ABDOMINAL PAIN UPPER 13 0.0001
806 PULMONARY EMBOLISM 6 0.0001
807 HALLUCINATION, AUDITORY 1 0.0001
808 CYSTITIS 2 0.0001
809 OBESITY 1 0.0001
810 MOOD SWINGS 2 0.0001
811 LOSS OF CONSCIOUSNESS 8 0.0001
812 HIP FRACTURE 2 0.0001
813 MUSCLE TIGHTNESS 1 0.0001
814 DEEP VEIN THROMBOSIS 4 0.0001
815 MULTIPLE FRACTURES 1 0.0001
816 HYPOAESTHESIA 9 0.0001
817 FUNGAL INFECTION 2 0.0001
818 AGGRESSION 3 0.0001
819 GAIT INABILITY 2 0.0001
820 BLOOD UREA INCREASED 1 0.0001
821 FACE OEDEMA 1 0.0001
822 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
823 SKIN EXFOLIATION 5 0.0001
824 HEMIPARESIS 1 0.0001
825 FLUSHING 6 0.0001
826 PRODUCT QUALITY ISSUE 8 0.0001
827 HEPATIC ENZYME INCREASED 4 0.0001
828 FEELING ABNORMAL 14 0.0001
829 MUSCULOSKELETAL DISCOMFORT 1 0.0001
830 ORTHOSTATIC HYPOTENSION 1 0.0001
831 NEUROTOXICITY 1 0.0001
832 HYPERKALAEMIA 2 0.0001
833 HEART RATE DECREASED 2 0.0001
834 DEPRESSED MOOD 3 0.0001
835 LYMPHOCYTE COUNT DECREASED 1 0.0001
836 DRUG ERUPTION 1 0.0001
837 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10 0.0001
838 GASTROENTERITIS VIRAL 1 0.0001
839 LEUKOCYTOSIS 1 0.0001
840 FATIGUE 43 0.0001
841 URTICARIA 9 0.0001
842 ABDOMINAL DISCOMFORT 9 0.0001
843 TOXICITY TO VARIOUS AGENTS 9 0.0001
844 HEPATIC CIRRHOSIS 1 0.0001
845 COLITIS 2 0.0001
846 ANXIETY 15 0.0001
847 MUSCULOSKELETAL DISORDER 1 0.0001
848 HERPES ZOSTER 3 0.0001
849 CHOLESTASIS 1 0.0001
850 ACUTE RESPIRATORY FAILURE 1 0.0001
851 ERUCTATION 1 0.0001
852 EAR PAIN 1 0.0001
853 PRODUCT DOSE OMISSION ISSUE 15 0.0001
854 KIDNEY INFECTION 1 0.0001
855 MENORRHAGIA 1 0.0001
856 DISEASE PROGRESSION 6 0.0001
857 DISCOMFORT 3 0.0000
858 NEUTROPHIL COUNT DECREASED 2 0.0000
859 MUSCLE SPASMS 9 0.0000
860 PERITONITIS 1 0.0000
861 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
862 ANAEMIA 9 0.0000
863 EATING DISORDER 1 0.0000
864 IMPAIRED WORK ABILITY 1 0.0000
865 LIVER FUNCTION TEST INCREASED 1 0.0000
866 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
867 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
868 DEVICE LEAKAGE 2 0.0000
869 SWELLING FACE 3 0.0000
870 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
871 MALAISE 20 0.0000
872 HOSPITALISATION 7 0.0000
873 FEBRILE NEUTROPENIA 3 0.0000
874 RENAL FAILURE 6 0.0000
875 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
876 COLITIS ULCERATIVE 2 0.0000
877 THROMBOCYTOPENIA 5 0.0000
878 VOMITING 21 0.0000
879 ORAL PAIN 1 0.0000
880 DEVICE ISSUE 4 0.0000
881 CHROMATURIA 1 0.0000
882 SUICIDAL IDEATION 4 0.0000
883 MUSCLE TWITCHING 1 0.0000
884 ARTHRALGIA 18 0.0000
885 BURNING SENSATION 3 0.0000
886 SWELLING 4 0.0000
887 CHILLS 5 0.0000
888 SLEEP DISORDER 3 0.0000
889 RASH ERYTHEMATOUS 2 0.0000
890 GAIT DISTURBANCE 8 0.0000
891 BLOOD GLUCOSE DECREASED 2 0.0000
892 MENTAL IMPAIRMENT 1 0.0000
893 FIBROMYALGIA 1 0.0000
894 INJECTION SITE URTICARIA 1 0.0000
895 COVID-19 7 0.0000
896 ACNE 3 0.0000
897 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
898 ANAPHYLACTIC SHOCK 1 0.0000
899 BACK PAIN 9 0.0000
900 HAEMORRHAGE 4 0.0000
901 DERMATITIS ATOPIC 2 0.0000
902 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
903 INJECTION SITE BRUISING 3 0.0000
904 MOOD ALTERED 1 0.0000
905 INFLUENZA LIKE ILLNESS 3 0.0000
906 HAEMATOCHEZIA 2 0.0000
907 ABNORMAL DREAMS 1 0.0000
908 MENTAL STATUS CHANGES 1 0.0000
909 INFLUENZA 4 0.0000
910 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
911 PAIN IN JAW 1 0.0000
912 HYPERSOMNIA 1 0.0000
913 PRODUCT SUBSTITUTION ISSUE 2 0.0000
914 ACUTE MYOCARDIAL INFARCTION 1 0.0000
915 LABORATORY TEST ABNORMAL 1 0.0000
916 CATARACT 2 0.0000
917 APHASIA 1 0.0000
918 LACRIMATION INCREASED 1 0.0000
919 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
920 INJECTION SITE RASH 1 0.0000
921 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
922 EMOTIONAL DISORDER 1 0.0000
923 LIMB DISCOMFORT 1 0.0000
924 FEMUR FRACTURE 1 0.0000
925 HEAD INJURY 1 0.0000
926 INTENTIONAL OVERDOSE 2 0.0000
927 MOVEMENT DISORDER 1 0.0000
928 DRUG INTOLERANCE 3 0.0000
929 AMNESIA 2 0.0000
930 PAIN IN EXTREMITY 9 0.0000
931 DYSPEPSIA 3 0.0000
932 IMPAIRED HEALING 1 0.0000
933 ANGER 1 0.0000
934 GASTRIC DISORDER 1 0.0000
935 NIGHTMARE 1 0.0000
936 NEOPLASM PROGRESSION 1 0.0000
937 MYOCARDIAL INFARCTION 5 0.0000
938 LYMPHADENOPATHY 1 0.0000
939 PLATELET COUNT DECREASED 3 0.0000
940 CEREBRAL HAEMORRHAGE 1 0.0000
941 MYELOSUPPRESSION 1 0.0000
942 PAIN 17 0.0000
943 CRYING 1 0.0000
944 ACCIDENTAL OVERDOSE 1 0.0000
945 INJECTION SITE MASS 1 0.0000
946 BRONCHITIS 2 0.0000
947 DYSGEUSIA 2 0.0000
948 HEPATIC FUNCTION ABNORMAL 1 0.0000
949 WEIGHT INCREASED 6 0.0000
950 INTESTINAL OBSTRUCTION 1 0.0000
951 MUSCULAR WEAKNESS 3 0.0000
952 INCORRECT DOSE ADMINISTERED 6 0.0000
953 PLASMA CELL MYELOMA 1 0.0000
954 CARDIAC FAILURE CONGESTIVE 2 0.0000
955 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
956 CEREBROVASCULAR ACCIDENT 4 0.0000
957 OSTEOARTHRITIS 1 0.0000
958 HYPOACUSIS 1 0.0000
959 MENTAL DISORDER 1 0.0000
960 ANGIOEDEMA 1 0.0000
961 LIVER DISORDER 1 0.0000
962 NO ADVERSE EVENT 4 0.0000
963 ARRHYTHMIA 1 0.0000
964 COLORECTAL CANCER 1 0.0000
965 INTERSTITIAL LUNG DISEASE 1 0.0000
966 FLUID RETENTION 1 0.0000
967 SINUSITIS 2 0.0000
968 NERVOUSNESS 1 0.0000
969 MUSCULOSKELETAL PAIN 1 0.0000
970 DEATH 16 0.0000
971 DRUG EFFECT DECREASED 1 0.0000
972 ARTHROPATHY 1 0.0000
973 BLISTER 1 0.0000
974 IRRITABILITY 1 0.0000
975 EMOTIONAL DISTRESS 2 0.0000
976 ILL-DEFINED DISORDER 1 0.0000
977 DEVICE DIFFICULT TO USE 1 0.0000
978 INJECTION SITE REACTION 1 0.0000
979 DEVICE MALFUNCTION 1 0.0000
980 INJURY 1 0.0000
981 HOT FLUSH 1 0.0000
982 ARTHRITIS 1 0.0000
983 DRUG DEPENDENCE 2 0.0000
984 MYALGIA 2 0.0000
985 ADVERSE DRUG REACTION 1 0.0000
986 CARDIAC DISORDER 1 0.0000
987 BLOOD GLUCOSE INCREASED 2 0.0000
988 INJECTION SITE PAIN 3 0.0000
989 JOINT SWELLING 1 0.0000
990 DRUG DOSE OMISSION 1 0.0000